Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Working Capital Changes (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Other Working Capital Changes for 16 consecutive years, with -$336215.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 683.46% year-over-year to -$336215.0, compared with a TTM value of -$308312.0 through Oct 2025, down 302.27%, and an annual FY2025 reading of -$308312.0, down 1527.7% over the prior year.
  • Other Working Capital Changes was -$336215.0 for Q4 2025 at Pharma-Bio Serv, down from $96317.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $757904.0 in Q3 2022 and bottomed at -$552175.0 in Q3 2021.
  • Average Other Working Capital Changes over 5 years is $38966.6, with a median of $14694.0 recorded in 2024.
  • The sharpest move saw Other Working Capital Changes soared 471.18% in 2024, then tumbled 683.46% in 2025.
  • Year by year, Other Working Capital Changes stood at $445558.0 in 2021, then tumbled by 55.67% to $197507.0 in 2022, then plummeted by 179.14% to -$156316.0 in 2023, then skyrocketed by 136.86% to $57624.0 in 2024, then crashed by 683.46% to -$336215.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for PBSV at -$336215.0 in Q4 2025, $96317.0 in Q3 2025, and -$30677.0 in Q2 2025.